Syndesi Therapeutics lands Series A funding


Syndesi Therapeutics, a Belgian neurology drug discovery startup, has raised 17 million euros in Series A funding. The investors included Novo Seeds, Fountain Healthcare, Johnson & Johnson Innovation – JJDC, Inc., V-BIO Ventures and the Walloon Investment Fund.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.